Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frauke M Schnorfeil

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecular Immunology|September 9, 2010
Differentially expressed microRNAs regulate plasmacytoid vs. conventional dendritic cell developmentHarmjan Kuipers, Frauke M Schnorfeil, Thomas Brocker
Journal of Immunology (Baltimore, Md. : 1950)|October 5, 2011
MicroRNAs regulate dendritic cell differentiation and functionMarian L Turner, Frauke M Schnorfeil, Thomas Brocker
Immunotherapy|December 22, 2012
Current strategies in immunotherapy for acute myeloid leukemiaFelix S Lichtenegger, Frauke M Schnorfeil, Wolfgang Hiddemann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2010
Dicer-dependent microRNAs control maturation, function, and maintenance of Langerhans cells in vivoHarmjan Kuipers, Frauke M Schnorfeil, Hans-Jörg Fehling, et al.
Journal of Hematology & Oncology|July 30, 2015
T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartmentFrauke M Schnorfeil, Felix S Lichtenegger, Katharina Emmerig, et al.
Frontiers in Immunology|March 15, 2018
Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting CellsFelix S Lichtenegger, Maurine Rothe, Frauke M Schnorfeil, et al.
Leukemia|July 28, 2023
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapyYngvar Fløisand, Mats Remberger, Iris Bigalke, et al.
Clinical & Translational Immunology|March 11, 2020
Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trialFelix S Lichtenegger, Frauke M Schnorfeil, Maurine Rothe, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecular Immunology|September 9, 2010
Differentially expressed microRNAs regulate plasmacytoid vs. conventional dendritic cell developmentHarmjan Kuipers, Frauke M Schnorfeil, Thomas Brocker
Journal of Immunology (Baltimore, Md. : 1950)|October 5, 2011
MicroRNAs regulate dendritic cell differentiation and functionMarian L Turner, Frauke M Schnorfeil, Thomas Brocker
Immunotherapy|December 22, 2012
Current strategies in immunotherapy for acute myeloid leukemiaFelix S Lichtenegger, Frauke M Schnorfeil, Wolfgang Hiddemann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2010
Dicer-dependent microRNAs control maturation, function, and maintenance of Langerhans cells in vivoHarmjan Kuipers, Frauke M Schnorfeil, Hans-Jörg Fehling, et al.
Journal of Hematology & Oncology|July 30, 2015
T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartmentFrauke M Schnorfeil, Felix S Lichtenegger, Katharina Emmerig, et al.
Frontiers in Immunology|March 15, 2018
Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting CellsFelix S Lichtenegger, Maurine Rothe, Frauke M Schnorfeil, et al.
Leukemia|July 28, 2023
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapyYngvar Fløisand, Mats Remberger, Iris Bigalke, et al.
Clinical & Translational Immunology|March 11, 2020
Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trialFelix S Lichtenegger, Frauke M Schnorfeil, Maurine Rothe, et al.
Pageof 1